High risk of long-term adverse events versus general population, irrespective of age.
Health system savings, health benefits with therapy for contacts of patients with multi-drug resistant TB.
Atypical presentations, including mild illness without fever, diarrheal illness, have been reported.
Patients hospitalized with macrolide-resistant S. pneumoniae not more severely ill at presentation.
Two studies have found that a single-dose vaccine for HPV may be just as effective as two- or three-dose counterparts.
A woman with a drug-resistant form of tuberculosis traveled in three U.S. states before getting treated.
The rates of children under five years that have been hospitalized for gastroenteritis has steadily decline.
In survey, more than half didn’t get vaccinated; many were unaware of risk.
New guidelines address issues that were not discussed in 2010 guidelines.
A new technology could allow a single test to determine an individual’s past and present viral infections.
Findings support immunization of older adults.
Testing rates of those ages 15 to 44: 22% for females and 16% for males.
Finding may explain why lens wearers are more prone to infection.
Second study shows high personal belief exemption schools are colocated with schools with elevated personal medical exemption rates.
Congenital cytomegalovirus is the leading cause of mental retardation and disability in children.
NIH-funded trial results appear likely to impact global treatment guidelines.
Physicians’ spending grew more slowly over 2003 to 2013 than hospital and clinical spending.
The Food and Drug Administration (FDA) announced that Factive (gemifloxacin mesylate; LG Life Sciences) is currently in shortage.
Meropenem has been approved by the Food and Drug Administration (FDA) for the treatment of abdominal infections in infants less than 3 months old.
U.S. Food and Drug Administration approves Viberzi (eluxadoline) and Xifaxan (rifaximin).
A new RAND Corporation Study has shown that patients are more likely to be prescribed a broad-spectrum antibiotic for an acute respiratory infection by a doctor on a telephone or live video than face-to-face for the same illness.
Study shows it helped a minority of patients, and experts say this approach has promise.
Study suggests improved coping for those whose loved ones had end-of-life care.
The FDA is warning healthcare providers about the risk for dosing errors with Zerbaxa (ceftolozane and tazobactam; Cubist) due to confusion of the strength displayed on the vial and carton labeling.
An outbreak of gastrointestinal illness that was traced back to an Oregon lake has led U.S. health officials to issue guidelines on swimming hygiene.
Scientists at the University of Minnesota have created a predictive model for measuring healthy development of bacteria in the gut of young children and a framework to map potential links between antibiotics, gut bacteria, and disease later in life.
The Food and Drug Administration (FDA) has issued a draft guidance for blood establishments that collect blood or blood components with recommended revisions to the donor deferral period for men who have sex with men (MSM).
Researchers have studied a new defense mechanism to explain how Escherichia coli can thrive during flare ups in patients with inflammatory bowel disease (IBD).
The Food and Drug Administration (FDA) has approved Avelox (moxifloxacin; Bayer) for the treatment of pneumonic and septicemic plague, and for the prevention of plague in adults.
A non-aggressive Clostridium difficile strain significantly reduced the risk of Clostridium difficile infection (CDI) recurrence.